| Structure |
Chemical Name |
CAS |
MF |
 |
D,L N,O-Didesmethylvenlafaxine |
135308-74-6 |
C15H23NO2 |
 |
Desmethyl Erlotinib Acetate |
183320-15-2 |
C23H23N3O5 |
 |
Erythromycin E_x000b_Discontinued |
41451-91-6 |
C37H65NO14 |
 |
Avermectin A1a, 25-cyclohexyl-4'-O-de(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-23-hydroxy-5-(hydroxyimino)-, (23S)- (9CI) |
165108-08-7 |
C43H63NO12 |
 |
2-(3,4-dihydroxyphenyl)acetaldehyde |
5707-55-1 |
C8H8O3 |
![1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetamide, N-[(1S)-1-[3-[3-[bis(methylsulfonyl)amino]-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl]-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bS,4aR)-](/CAS/20211123/GIF/2189684-58-8.gif) |
1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetamide, N-[(1S)-1-[3-[3-[bis(methylsulfonyl)amino]-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl]-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bS,4aR)- |
2189684-58-8 |
C40H34ClF10N7O7S3 |
 |
NSC 77154 |
4121-39-5 |
C8H9N5 |
 |
N-Methyl-N,N-bis(2-pyridylethyl)amine |
5452-87-9 |
C15H19N3 |
 |
(S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine |
147769-93-5 |
C16H26N2 |
|
|
AMIKACIN IMPURITY A |
|
|
|
|
ONDANSETRON IMPURITY D |
|
|
|
|
PERINDOPRIL IMPURITY A |
|
|
|
|
NICERGOLINE IMP. D (EP): 5-BROMOPYRIDINE-3-CARBOXYLIC ACID |
|
|
![AMOXICILLIN TRIHYDRATE IMP. D (EP) AS SODIUM SALT:(4S)-2-[[[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL]AMINO]-CARBOXYMETHYL]-5,5-DIMETHYLTHIAZOLIDINE-4-CARBOXYLIC ACID SODIUM SALT (PENICILLOICACIDS OF AMO](/CAS/20211123/GIF/1642629-94-4.gif) |
AMOXICILLIN TRIHYDRATE IMP. D (EP) AS SODIUM SALT:(4S)-2-[[[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL]AMINO]-CARBOXYMETHYL]-5,5-DIMETHYLTHIAZOLIDINE-4-CARBOXYLIC ACID SODIUM SALT (PENICILLOICACIDS OF AMO |
1642629-94-4 |
C16H21N3O6S |
 |
4-CHLORO-6-(2-CHLORO-ETHOXY)-7-(2-METHOXY-ETHOXY)-QUINAZOLINE |
183322-19-2 |
C13H14Cl2N2O3 |
 |
2-PIPERAZINE-4-AMINO-6,7-DIMETHOXY QUINOLINE HYDROCHLORIDE |
84050-22-6 |
C14H20ClN5O2 |
 |
2-CHLORO-N-(2,3-DIMETHYL-PHENYL)-ACETAMIDE |
2564-07-0 |
C10H12ClNO |
 |
1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl)-pyridine-3,5-dicarboxylic acid monoisopropyl ester |
116983-17-6 |
C18H20N2O6 |
 |
3-(3-TRIFLUOROMETHYL-PHENYL)-PROPYLAMINE |
104774-87-0 |
C10H12F3N |
 |
4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one |
124379-29-9 |
C16H12Cl2O |
 |
(4-(2-(azepan-1-yl)ethoxy)phenyl)Methanol |
223251-16-9 |
C15H23NO2 |
 |
4-HYDROXY PROPOFOL |
1988-10-9 |
C12H18O2 |
 |
(1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid |
220352-36-3 |
C10H8F2O2 |
 |
1-((2R,3R)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one |
2243786-01-6 |
C30H35N5O3 |
 |
4-(CHLOROMETHYL)BENZYL ALCOHOL 99 |
16473-35-1 |
C8H9ClO |
 |
4,4′-DIPHENOQUINONE (DQ) |
494-72-4 |
C12H8O2 |
 |
S-(+)-O-DESMETHYL VENLAFAXINE |
142761-12-4 |
C16H25NO2 |
 |
ACETYLSIMVASTATIN |
145576-25-6 |
C27H40O6 |
![5-[2-(4'-METHYLBIPHENYL)]TETRAZOLE](/CAS/GIF/120568-11-8.gif) |
5-[2-(4'-METHYLBIPHENYL)]TETRAZOLE |
120568-11-8 |
C14H12N4 |
 |
L-2-Aminobutanamide |
7324-11-0 |
C4H10N2O |
 |
FUROSEMIDE IMPURITY A |
|
C12H11ClN2O5S |
|
|
GLICLAZIDE IMPURITY F |
|
|
 |
(E)-Ceftiofur |
120882-20-4 |
C19H17N5O7S3 |
|
|
Cefmetazole Impurity E |
|
|
|
|
Aztreonam USP Impurity B |
|
|
 |
Azlocillin Opern-Ring Decarboxylation Impurity |
99795-14-9 |
C19H25N5O5S |
 |
Cefotiam Impurity 1 |
2243596-87-2 |
C18H23N9O4S3 |
|
|
Eribulin Impurity 3 |
|
|
|
|
sodium 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)-1-oxidopiperazin-1-yl)ethoxy)acetate |
|
|
 |
Brivaracetam Impurity 25 |
10547-88-3 |
C7H12O2 |
|
|
(S)-N-((R)-1-amino-1-oxobutan-2-yl)-3-(bromomethyl)hexanamide |
|
|
|
|
Peramivir Impurity 19 |
|
|
 |
Diquafosol Impurity 13 |
211448-81-6 |
C18H28N4O29P6 |
 |
Montelukast Sodium EP Impurity G |
1428448-96-7 |
C35H37ClNNaO3S |
 |
Amifostine related impurities 2 |
17002-55-0 |
C8H21N3O |
 |
Oxacillin Impurity F |
5053-35-0 |
C19H19N3O4S2 |
 |
Peramivir Impurity 30 |
2758048-79-0 |
C20H36N2O6 |
|
|
Cabozantinib impurity 37 |
|
|
|
|
4-(1-bromoethyl)-6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidine |
|
|
|
|
ethyl 6-bromo-4,7-bis((dimethylamino)methyl)-5-hydroxy-1-methyl-2-((phenylthio)methyl)-1H-indole-3-carboxylate |
|
|
|
|
Dapoxetine impurity 53 |
|
|
|
|
Dapoxetine impurity 70 |
|
|
 |
Bosutinib Impurity 38 |
2095306-26-4 |
C46H44Cl4N8O6 |
 |
(2RS)-2-(4-ETHYLPHENYL)PROPANOIC ACID |
3585-52-2 |
C11H14O2 |
|
|
Ceftriaxone IMpurit C |
|
|
|
|
Flucloxacillin IMpurity G |
|
|
 |
Gefitinib N-Oxide |
847949-51-3 |
C22H24ClFN4O4 |
 |
Milrinone IMpurity 3 |
98293-81-3 |
C12H7N3O3 |
 |
Nicardipine Related CoMpound 4 |
123973-71-7 |
C25H27N3O6 |
|
|
PraMipexole IMp.BI-II786BS |
|
|
|
|
Propofol IMpurity E |
|
|
|
|
Solifenacin Related CoMpound 5 |
|
|
 |
TelMisartan BroMo Ethyl Ester |
133085-87-7 |
C16H15BrO2 |
 |
Tolterodine Lactol IMpurity |
209747-04-6 |
C16H16O2 |
|
|
Valsartan N1-Trityl IMpurity |
|
|
 |
(3-Carbamoylallyl)trimethylammonium |
857162-57-3 |
C7H15N2O+ |
 |
3-CHLORO-4-HYDROXYACETANILIDE |
3964-54-3 |
C8H8ClNO2 |
|
|
Apixaban IMpurity(BMS-591329-01) |
|
|
 |
ent-14S-3-Methoxy-17-MethylMorphinan |
1453167-99-1 |
C18H25NO |
 |
PD 224378 |
501665-88-9 |
C20H35NO11 |
 |
(rac,syn)-4-Deschloro-sertraline |
871838-58-3 |
C17H18ClN |
![1-[2-(DiMethylaMino)-1-phenylethyl]cyclohexanol](/CAS/20150408/GIF/93413-86-6.gif) |
1-[2-(DiMethylaMino)-1-phenylethyl]cyclohexanol |
93413-86-6 |
C16H25NO |
![1-[4-(2-Methoxyethenyl)phenoxy]-3-[(1-Methylethyl)aMino]-2-propanol](/CAS/20150408/GIF/82961-02-2.gif) |
1-[4-(2-Methoxyethenyl)phenoxy]-3-[(1-Methylethyl)aMino]-2-propanol |
82961-02-2 |
C15H23NO3 |
 |
11-Desethyl Irinotecan |
103816-16-6 |
C31H34N4O6 |
![5-Methoxy-2-[[(4-Methoxy-3,5-diMethyl-2-pyridinyl)Methyl]thio]-1H-benziMidazole N-Oxide](/CAS/20150408/GIF/142885-92-5.gif) |
5-Methoxy-2-[[(4-Methoxy-3,5-diMethyl-2-pyridinyl)Methyl]thio]-1H-benziMidazole N-Oxide |
142885-92-5 |
C17H19N3O3S |
![7-[[[(CyanoMethyl)thio]acetyl]aMino]-7-Methoxy Cephalosporanic Acid](/CAS/GIF/56796-16-8.gif) |
7-[[[(CyanoMethyl)thio]acetyl]aMino]-7-Methoxy Cephalosporanic Acid |
56796-16-8 |
C15H17N3O7S2 |
 |
7S-Cefdinir |
178601-89-3 |
C14H13N5O5S2 |
 |
Dehydroxy BroMocelecoxib |
170570-75-9 |
C17H13BrF3N3O2S |
 |
Desethylene Norfloxacin Hydrochloride |
75001-77-3 |
C14H16FN3O3 |
 |
p-(2,3-Epoxypropoxy)benzyl Alcohol |
4204-78-8 |
C10H12O3 |
 |
5-(3-fluorophenyl)-1H-pyrrole-3-carbaldehyde |
|
C11H8FNO |
 |
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid bis(1-methylethyl) ester |
21881-78-7 |
C21H26N2O6 |
 |
2-(4-Methylphenyl)sulfonyloxyethanol |
42772-85-0 |
C9H12O4S |
![2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-](/CAS/20200611/GIF/1564265-94-6.gif) |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- |
1564265-94-6 |
C18H25N3O2 |
|
|
EMpagliflozin iMpurity 8 |
|
|
 |
EMpagliflozin iMpurity 13 |
2125472-55-9 |
C23H25ClO8 |
 |
6-Methyldi(ondansetron-3-de(1,2-diMethyl-1H-iMidazole)) |
1365727-07-6 |
C27H26N2O2 |
 |
(-)-Syringaresinol-4-O-beta-D-glucopyranoside |
137038-13-2 |
C28H36O13 |
 |
Budesonide Impurity (1, 4-Androstadien-11-beta-16-alfa-diol-3, 17-dione) |
910299-74-0 |
C19H24O4 |
 |
Etoricoxib Impurity 12 |
646459-41-8 |
C21H16ClN3O2S |
 |
Levofloxacin Tetrafluoro Impurity 2 |
103995-33-1 |
C14H12F4O4 |
 |
Mupirocin Impurity C |
|
C26H44O9 |
 |
Verapamil Impurity H |
67018-83-1 |
C26H36N2O4 |
 |
Warfarin Impurity 1 |
55901-61-6 |
C13H14O |
 |
Vitexin -4''-O-glucoside |
178468-00-3 |
C27H30O15 |
|
|
Aripiprazole EP impurity D |
|
|
 |
Macitentan impurity B |
441796-13-0 |
C18H18Br2N6O4S |
|
|
Meropenem IMP B |
|
|
 |
tert-butyl 4-(6-bromopyridin-3-yl)piperazine-1-carboxylate |
412348-27-7 |
C14H20BrN3O2 |
 |
ETHYL 3,4-EPOXYBUTANOATE |
32223-97-5 |
C6H10O3 |